ABSTRACT
The retinal pigment epithelium (RPE) is essential for eye development by interacting with the overlaying neuroepithelium. Regulatory sequences of the gene encoding for tyrosinase-related protein 1 (TRP-1), linked to the lacZ reporter gene, lead to strong and specific beta-galactosidase expression in the RPE. We asked how the oncogene ret would affect this epithelial cell type during mouse development. We used the TRP-1 promoter to express ret in the developing RPE, and obtained transgenic mouse lines, which showed mild to severe microphthalmia. During development, the RPE changed to a stratified epithelium with reduced or absent pigmentation from E10.5 onward. In addition, proliferation of RPE cells and tumor formation were observed from E12.5 onward. These early events prevent closure of choroid fissure and lead to microphthalmia and secondary malformations after birth. We conclude that ret transgene expression in the RPE prevents normal differentiation of this epithelial layer and induces proliferation and tumor formation. The appearance of the microphthalmic phenotype underlines the requirement of a normally developed RPE for eye development.
Subject(s)
Drosophila Proteins , Eye Neoplasms/genetics , Membrane Glycoproteins , Microphthalmos/genetics , Oxidoreductases , Pigment Epithelium of Eye , Proteins/metabolism , Proto-Oncogene Proteins/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Animals , Eye Neoplasms/embryology , Eye Neoplasms/pathology , Female , Gene Expression , Lac Operon , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Transgenic , Pigment Epithelium of Eye/embryology , Proteins/genetics , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-ret , Receptor Protein-Tyrosine Kinases/genetics , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolismABSTRACT
In transgenic experiments, lacZ can be used as a reporter gene for activity of a given promoter. Its main advantage is the ease of visualization in situ, on sections or in whole mount preparations, and the availability of simple protocols. In the following, we describe our procedure for detecting promoter activity in transgenic mice, including choice of lacZ vectors, generation of the transgenic mice, and analysis of expression. We had recently used this protocol to detect tyrosinase gene promoter activity in embryonic and adult brain.
Subject(s)
Gene Expression Regulation, Developmental/physiology , Lac Operon , Promoter Regions, Genetic , Animals , Embryo, Mammalian/physiology , Mice , Mice, Transgenic , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
Tyrosinase and tyrosinase-related proteins (TRP-1 and TRP-2) are essential for melanin synthesis and are expressed in neural crest-derived melanocytes and in the pigment epithelium of the retina. Recent results suggest expression of all three proteins within the central nervous system. We performed a transgenic assay using beta-galactosidase as reporter gene to monitor tyrosinase promoter activity in vivo. During embryogenesis, we found expression in several locations of developing forebrain and midbrain. Tyrosinase, TRP-1 and TRP-2 had been equally found in extracts of adult mouse brain. In adult brain, we detected tyrosinase promoter activity in cortex, olfactory system, hippocampus, epithalamus and substantia nigra, areas corresponding to positive staining during embryogenesis. Thus, tyrosinase promoter is active throughout murine brain development, and tyrosinase could be implicated in neuromelanin formation in the substantia nigra, and in neurodegenerative disorders like Parkinson's disease.
Subject(s)
Brain/metabolism , Gene Expression Regulation, Developmental , Intramolecular Oxidoreductases/biosynthesis , Membrane Glycoproteins , Mesencephalon/metabolism , Monophenol Monooxygenase/biosynthesis , Oxidoreductases , Prosencephalon/metabolism , Protein Biosynthesis , Substantia Nigra/metabolism , Animals , Brain/growth & development , Intramolecular Oxidoreductases/analysis , Mice , Mice, Transgenic , Monophenol Monooxygenase/analysis , Organ Specificity , Promoter Regions, Genetic , Proteins/analysis , Recombinant Fusion Proteins/biosynthesis , beta-Galactosidase/biosynthesisABSTRACT
The enzyme tyrosinase is indispensable for pigmentation and the gene is expressed mainly in pigment cells. Regulatory elements, at -12 to -15 kb (enhancer) and within the 270 bp directly upstream of the transcription start site, have been described recently and their importance demonstrated in transgenic experiments. We were interested in tyrosinase promoter activity during development and used beta-galactosidase as reporter gene. Transgenic mice were generated carrying a tyrosinase-lacZ fusion gene, containing 6.1 kb of tyrosinase 5' sequences. In transgenic embryos, beta-galactosidase activity was detected along the entire neural tube, with the most prominent expression in the developing telencephalon, and also in the adult brain. Equivalent expression was observed in the developing retina. Tyrosinase protein was identified in embryonic and adult brain, but no DOPAoxidase or tyrosine hydroxylase activity was detected. From our results we conclude that 1) tyrosinase protein is present in embryonic and adult mouse brain and 2) the tyrosinase promoter can direct expression of a reporter gene to pigment cells and neural tissues.
Subject(s)
Brain/metabolism , Fetal Proteins/biosynthesis , Gene Expression Regulation, Developmental , Monophenol Monooxygenase/genetics , Nerve Tissue Proteins/biosynthesis , Promoter Regions, Genetic , Animals , Brain/embryology , Brain/growth & development , Enzyme Induction , Fetal Proteins/genetics , Genes, Reporter , Mice , Mice, Transgenic , Monophenol Monooxygenase/biosynthesis , Nerve Tissue Proteins/genetics , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/genetics , Telencephalon/embryology , Telencephalon/growth & development , Telencephalon/metabolism , Transcription, Genetic , beta-Galactosidase/biosynthesis , beta-Galactosidase/geneticsABSTRACT
Tyrosinase is one of the key enzymes in mammalian melanin synthesis. The pigment is produced in two different cell types: the pigmented epithelial cell of the retina, and the melanocyte, a cell of neural-crest origin. We recently showed that a fusion gene between regulatory sequences of tyrosinase gene (tyr) and the beta-galactosidase gene (lacZ), when introduced into transgenic mice, resulted in embryonic expression in presumptive pigment cells but also in cells populations along the entire neural tube. This expression in the developing brain was striking, and we therefore asked whether this would still be detectable after birth. Transgenic mice carrying the tyr-lacZ fusion gene showed beta-galactosidase expression in adult brain. On Western blots, we detected tyrosinase-specific bands of 65-68 kDa in brain and eye. Using an affinity-purified antibody, we showed that detection of tyrosinase is specific and competed off by the presence of the cognate tyrosinase-derived peptide. However, neither tyrosine hydroxylase nor Dopa oxidase activity were detected in protein extracts of brain. We therefore suggest that tyrosinase is present in brain but either not functional or catalyzing different reactions compared to pigment cells.
Subject(s)
Brain/enzymology , Melanins/biosynthesis , Monophenol Monooxygenase/metabolism , Animals , Blotting, Northern , Blotting, Western , Cell Extracts/chemistry , Gene Expression Regulation/genetics , Lac Operon/genetics , Melanocytes/metabolism , Mice , Mice, Transgenic , Monophenol Monooxygenase/analysis , Polymerase Chain Reaction , RNA, Messenger/analysis , RNA, Messenger/metabolism , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Sodium Channels , Tyrosine 3-Monooxygenase/analysis , beta-Galactosidase/genetics , beta-Galactosidase/metabolismABSTRACT
Tyrosinase, the key enzyme in melanin synthesis, is expressed in pigment cells derived from both neural crest and neuroectoderm. The present study was performed to detect tyrosinase promoter activity and tyrosinase gene expression during murine brain development. Mouse tyrosinase 5' region (6.1 Kb) was used to direct lacZ expression in transgenic mice. During embryogenesis, the transgene reproduced tyrosinase expression in pigment cells but was also observed in embryonic neuroectoderm and migrating neural crest cells. Both tyrosinase and lacZ were detected in cell populations often organized in columnar arrangements and found throughout the entire neural tube, in the cranial region as well as in the spinal chord. In the developing brain, the highest density of positive cells was localized to ventricular and subventricular zones and to evaginations of the neural tube such as optic vesicle, pineal gland, and olfactory bulbs. These results demonstrate that tyrosinase promoter activity and tyrosinase expression are not restricted to differentiated pigment cells. We suggest that tyrosinase is a new marker for cell populations in the neural tube, and that expression is correlated to regions undergoing rapid cell proliferation.
Subject(s)
Brain/growth & development , Monophenol Monooxygenase/metabolism , Animals , Brain/embryology , Brain/metabolism , Cell Count , Cranial Nerves/metabolism , Gene Expression , Head/anatomy & histology , Head/embryology , Lac Operon , Mice , Mice, Transgenic , Monophenol Monooxygenase/genetics , Promoter Regions, Genetic , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Spinal Cord/enzymologyABSTRACT
Using denaturing gradient gel electrophoresis and direct sequencing of amplified genomic DNA, we have identified two defective mutants of the human alpha 1-antichymotrypsin (ACT) gene associated with chronic obstructive pulmonary disease (COPD). A leucine 55-to-proline substitution causing a defective ACT allele (Bochum-1) was observed in a family with COPD in three subsequent generations. Another mutation, proline 229-to-alanine (Bonn-1), was associated with ACT serum deficiency in four patients with a positive family history. These mutations were not detected among 100 healthy control subjects, suggesting a possible pathogenetic role of ACT gene defects in a subset of patients with COPD.